Search Results 761-770 of 17088 for monoclonal antibody

  1. A Study of CMB305 and Atezolizumab in Patients with Sarcoma - Mayo Clinic

    ... monoclonal antibodies, fusion proteins, or CHO cell products. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  2. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

    - History of severe hypersensitivity to another monoclonal antibody - Other concurrent cancer or a history of another invasive malignancy within the last 3

  3. Publications - Todd J. Schwedt, M.D. - Mayo Clinic

    CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache. Cephalalgia. 2021 May ...

  4. A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets - Mayo Clinic

    therapy, including a proteasome inhibitors (PI), an Immunomodulatory drugs (IMID), and an anti-CD38 monoclonal antibody. - Permitted to be venetoclax or BCL ...

  5. Tumors And Masses Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  6. Publications - Bobbi S. Pritt, M.D. - Mayo Clinic

    Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes. JAMA Netw Open. 2023 Apr 3; 6 (4):e239694 Epub 2023 Apr 03. View PubMed; Venkatakrishnan ...

  7. Immune globulin and hyaluronidase (subcutaneous route) - Mayo Clinic

    Immune globulin and recombinant human hyaluronidase injection contains antibodies that make your immune system stronger. It is used for patients who have ...

  8. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

    Participation eligibility · Chemotherapy < 21 days prior to first administration of study treatment and/or monoclonal antibody < 6 weeks prior to first ...

  9. Cryoglobulinemia - Symptoms and causes - Mayo Clinic

    There are three types of cryoglobulinemia. Type 1. This type has one kind of atypical protein, called monoclonal. Type 1 most often is linked to blood cancers.

  10. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

    Any prior treatment with CD38 targeting monoclonal antibodies, including daratumumab or isatuximab-irfc;; Administration of the Janssen COVID-19 vaccine ...